135 related articles for article (PubMed ID: 31941926)
21. Transgenic Expression of Osteoactivin/gpnmb Enhances Bone Formation In Vivo and Osteoprogenitor Differentiation Ex Vivo.
Frara N; Abdelmagid SM; Sondag GR; Moussa FM; Yingling VR; Owen TA; Popoff SN; Barbe MF; Safadi FF
J Cell Physiol; 2016 Jan; 231(1):72-83. PubMed ID: 25899717
[TBL] [Abstract][Full Text] [Related]
22. The molecular mechanism of Nrf2-Keap1 signaling pathway in the antioxidant defense response induced by BaP in the scallop Chlamys farreri.
Wang H; Pan L; Xu R; Si L; Zhang X
Fish Shellfish Immunol; 2019 Sep; 92():489-499. PubMed ID: 31220575
[TBL] [Abstract][Full Text] [Related]
23. Hepatocyte-specific Keap1 deletion reduces liver steatosis but not inflammation during non-alcoholic steatohepatitis development.
Ramadori P; Drescher H; Erschfeld S; Schumacher F; Berger C; Fragoulis A; Schenkel J; Kensler TW; Wruck CJ; Trautwein C; Kroy DC; Streetz KL
Free Radic Biol Med; 2016 Feb; 91():114-26. PubMed ID: 26698665
[TBL] [Abstract][Full Text] [Related]
24. Activation of the Keap1/Nrf2 stress response pathway in autophagic vacuolar myopathies.
Duleh S; Wang X; Komirenko A; Margeta M
Acta Neuropathol Commun; 2016 Oct; 4(1):115. PubMed ID: 27799074
[TBL] [Abstract][Full Text] [Related]
25. p62/SQSTM1 protects against cisplatin-induced oxidative stress in kidneys by mediating the cross talk between autophagy and the Keap1-Nrf2 signalling pathway.
Liao W; Wang Z; Fu Z; Ma H; Jiang M; Xu A; Zhang W
Free Radic Res; 2019 Jul; 53(7):800-814. PubMed ID: 31223046
[TBL] [Abstract][Full Text] [Related]
26. Epigallocatechin gallate upregulates NRF2 to prevent diabetic nephropathy via disabling KEAP1.
Sun W; Liu X; Zhang H; Song Y; Li T; Liu X; Liu Y; Guo L; Wang F; Yang T; Guo W; Wu J; Jin H; Wu H
Free Radic Biol Med; 2017 Jul; 108():840-857. PubMed ID: 28457936
[TBL] [Abstract][Full Text] [Related]
27. Nrf2 expression driven by Foxp3 specific deletion of Keap1 results in loss of immune tolerance in mice.
Klemm P; Rajendiran A; Fragoulis A; Wruck C; Schippers A; Wagner N; Bopp T; Tenbrock K; Ohl K
Eur J Immunol; 2020 Apr; 50(4):515-524. PubMed ID: 31840803
[TBL] [Abstract][Full Text] [Related]
28. The discovery and characterization of K-563, a novel inhibitor of the Keap1/Nrf2 pathway produced by Streptomyces sp.
Hori R; Yamaguchi K; Sato H; Watanabe M; Tsutsumi K; Iwamoto S; Abe M; Onodera H; Nakamura S; Nakai R
Cancer Med; 2019 Mar; 8(3):1157-1168. PubMed ID: 30735010
[TBL] [Abstract][Full Text] [Related]
29. LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in
Galan-Cobo A; Sitthideatphaiboon P; Qu X; Poteete A; Pisegna MA; Tong P; Chen PH; Boroughs LK; Rodriguez MLM; Zhang W; Parlati F; Wang J; Gandhi V; Skoulidis F; DeBerardinis RJ; Minna JD; Heymach JV
Cancer Res; 2019 Jul; 79(13):3251-3267. PubMed ID: 31040157
[TBL] [Abstract][Full Text] [Related]
30. A Naturally-Occurring Dominant-Negative Inhibitor of Keap1 Competitively against Its Negative Regulation of Nrf2.
Qiu L; Wang M; Zhu Y; Xiang Y; Zhang Y
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30042301
[TBL] [Abstract][Full Text] [Related]
31. NF-E2-related factor 2 promotes compensatory liver hypertrophy after portal vein branch ligation in mice.
Shirasaki K; Taguchi K; Unno M; Motohashi H; Yamamoto M
Hepatology; 2014 Jun; 59(6):2371-82. PubMed ID: 24443206
[TBL] [Abstract][Full Text] [Related]
32. Bardoxolone ameliorates TGF-β1-associated renal fibrosis through Nrf2/Smad7 elevation.
Song MK; Lee JH; Ryoo IG; Lee SH; Ku SK; Kwak MK
Free Radic Biol Med; 2019 Jul; 138():33-42. PubMed ID: 31059771
[TBL] [Abstract][Full Text] [Related]
33. NRF2 pathway activation by KEAP1 inhibition attenuates the manifestation of aging phenotypes in salivary glands.
Wati SM; Matsumaru D; Motohashi H
Redox Biol; 2020 Sep; 36():101603. PubMed ID: 32590331
[TBL] [Abstract][Full Text] [Related]
34. Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression.
Nezu M; Suzuki N; Yamamoto M
Am J Nephrol; 2017; 45(6):473-483. PubMed ID: 28502971
[TBL] [Abstract][Full Text] [Related]
35. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
Namani A; Matiur Rahaman M; Chen M; Tang X
BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329
[TBL] [Abstract][Full Text] [Related]
36. Roles of Keap1-Nrf2 system in upper aerodigestive tract carcinogenesis.
Ohkoshi A; Suzuki T; Ono M; Kobayashi T; Yamamoto M
Cancer Prev Res (Phila); 2013 Feb; 6(2):149-59. PubMed ID: 23250896
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-1225 activates Keap1-Nrf2-HO-1 signalling to inhibit TNFα-induced osteoclastogenesis by mediating ROS generation.
Reziwan K; Sun D; Zhang B; Zhao Z
Cell Biochem Funct; 2019 Jun; 37(4):256-265. PubMed ID: 31017694
[TBL] [Abstract][Full Text] [Related]
38. Preconditioning the immature lung with enhanced Nrf2 activity protects against oxidant-induced hypoalveolarization in mice.
Tamatam CM; Reddy NM; Potteti HR; Ankireddy A; Noone PM; Yamamoto M; Kensler TW; Reddy SP
Sci Rep; 2020 Nov; 10(1):19034. PubMed ID: 33149211
[TBL] [Abstract][Full Text] [Related]
39. Hyperactivation of Nrf2 in early tubular development induces nephrogenic diabetes insipidus.
Suzuki T; Seki S; Hiramoto K; Naganuma E; Kobayashi EH; Yamaoka A; Baird L; Takahashi N; Sato H; Yamamoto M
Nat Commun; 2017 Feb; 8():14577. PubMed ID: 28233855
[TBL] [Abstract][Full Text] [Related]
40. Dysregulation of Nrf2/Keap1 Redox Pathway in Diabetes Affects Multipotency of Stromal Cells.
Rabbani PS; Soares MA; Hameedi SG; Kadle RL; Mubasher A; Kowzun M; Ceradini DJ
Diabetes; 2019 Jan; 68(1):141-155. PubMed ID: 30352880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
